{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:03:14Z","timestamp":1769115794033,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Diakonhjemmet Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to summarise effects and use of non-pharmacological and pharmacological treatments for sarcoidosis with musculoskeletal manifestations. We systematically searched the Cochrane Library, Ovid MEDLINE, Embase, CINAHL, AMED, Scopus, clinical.trials.gov, PROSPERO and PEDro for systematic reviews from 2014 to 2022 and for primary studies from date of inception to March 29, 2022, and studies with patients diagnosed with sarcoidosis with musculoskeletal manifestations. Inclusion criteria required that studies reported effects of non-pharmacological and\/or pharmacological treatments or number of patients receiving these treatments. Results were reported narratively and in forest plots. Eleven studies were included. No systematic reviews fulfilled our inclusion criteria. None of the included studies had a control group. We found that between 23 and 100% received corticosteroids, 0\u2013100% received NSAIDs, 5\u2013100% received hydroxychloroquine, 12\u2013100% received methotrexate, 0\u2013100% received TNF inhibitors, and 3\u20134% received azathioprine. Only ten patients in one study had used non-pharmacological treatments, including occupational therapy, chiropractic and acupuncture. There are no controlled studies on treatment effects for patients with sarcoidosis with musculoskeletal manifestations. We found 11 studies reporting use of pharmacological treatments and only one study reporting use of non-pharmacological treatments. Our study identified major research gaps for pharmacological and non-pharmacological treatment in musculoskeletal sarcoidosis and warrant randomised clinical trials for both.<\/jats:p>","DOI":"10.1007\/s00296-022-05171-8","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T04:02:52Z","timestamp":1660017772000},"page":"2109-2124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-1213","authenticated-orcid":false,"given":"Geir","family":"Smedslund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-007X","authenticated-orcid":false,"given":"Annie Martina","family":"Kotar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-9552","authenticated-orcid":false,"given":"Till","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"5171_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1573397114666180425111901","volume":"15","author":"S Shariatmaghani","year":"2019","unstructured":"Shariatmaghani S, Salari R, Sahebari M, Tabrizi PS, Salari M (2019) Musculoskeletal manifestations of sarcoidosis: a review article. Curr Rheumatol Rev 15:83\u201389","journal-title":"Curr Rheumatol Rev"},{"key":"5171_CR2","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","volume":"48","author":"EV Arkema","year":"2016","unstructured":"Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J (2016) Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J 48:1690\u20131699","journal-title":"Eur Respir J"},{"key":"5171_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jama.2011.10","volume":"305","author":"MC Iannuzzi","year":"2011","unstructured":"Iannuzzi MC, Fontana JR (2011) Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA 305:391\u2013399","journal-title":"JAMA"},{"key":"5171_CR4","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/1756-185X.13349","volume":"21","author":"Arthritis in Sarcoidosis G, Agarwal","year":"2018","unstructured":"Arthritis in Sarcoidosis G, Agarwal V, Agrawal V, Aggarwal A, Aggarwal P, Chowdhury AC, et al (2018) Arthritis in sarcoidosis: a multicentric study from India. Int J Rheum Dis 21:1728\u20131733","journal-title":"Int J Rheum Dis"},{"key":"5171_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jbspin.2019.10.001","volume":"87","author":"M Rubio-Rivas","year":"2020","unstructured":"Rubio-Rivas M, Franco J, Corbella X (2020) Sarcoidosis presenting with and without Lofgren\u2019s syndrome: Clinical, radiological and behavioral differences observed in a group of 691patients. Joint Bone Spine 87:141\u2013147","journal-title":"Joint Bone Spine"},{"key":"5171_CR6","first-page":"24","volume":"37","author":"MH Jeon","year":"2020","unstructured":"Jeon MH, Kang T, Yoo SH, Swan HS, Kim HJ, Ahn HS (2020) The incidence, comorbidity and mortality of sarcoidosis in Korea, 2008\u20132015: a nationwide population-based study. Sarcoidosis Vasc Diffuse Lung Dis 37:24\u201326","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"5171_CR7","first-page":"325","volume":"7","author":"SH Beegle","year":"2013","unstructured":"Beegle SH, Barba K, Gobunsuy R, Judson MA (2013) Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Des Dev Ther 7:325\u2013338","journal-title":"Drug Des Dev Ther"},{"key":"5171_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/MCP.0000000000000612","volume":"25","author":"RP Baughman","year":"2019","unstructured":"Baughman RP, Wells A (2019) Advanced sarcoidosis. Curr Opin Pulm Med 25:497\u2013504","journal-title":"Curr Opin Pulm Med"},{"key":"5171_CR9","unstructured":"Hammam N, Evans M, Morgan E, Reimold A, Anastasiou C, Kay JL, et al. (2020) Treatment of Sarcoidosis in U.S. Rheumatology Practices: Data from ACR\u2019s Rheumatology Informatics System for Effectiveness (RISE) Registry. Arthritis Care & Research n\/a."},{"key":"5171_CR10","first-page":"1","volume":"77","author":"B Wallaert","year":"2020","unstructured":"Wallaert B, Kyheng M, Labreuche J, Stelianides S, Wemeau L, Grosbois JM (2020) Long-term effects of pulmonary rehabilitation on daily life physical activity of patients with stage IV sarcoidosis: a randomized controlled trial. Respir Med Res 77:1\u20137","journal-title":"Respir Med Res"},{"key":"5171_CR11","unstructured":"Moola S. Systematic reviews of etiology and risk in Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute; 2017."},{"key":"5171_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, Rucker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22:153\u2013160","journal-title":"Evid Based Ment Health"},{"key":"5171_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.semarthrit.2018.10.005","volume":"48","author":"BL Adler","year":"2019","unstructured":"Adler BL, Wang CJ, Bui TL, Schilperoort HM, Armstrong AW (2019) Anti-tumor necrosis factor agents in sarcoidosis: a systematic review of efficacy and safety. Semin Arthritis Rheum 48:1093\u20131104","journal-title":"Semin Arthritis Rheum"},{"key":"5171_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MCP.0000000000000400","volume":"23","author":"RP Baughman","year":"2017","unstructured":"Baughman RP, Papanikolaou I (2017) Current concepts regarding calcium metabolism and bone health in sarcoidosis. Curr Opin Pulm Med 23:476\u2013481","journal-title":"Curr Opin Pulm Med"},{"key":"5171_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/rheumatology\/kex317","volume":"57","author":"K Bechman","year":"2018","unstructured":"Bechman K, Christidis D, Walsh S, Birring SS, Galloway J (2018) A review of the musculoskeletal manifestations of sarcoidosis. Rheumatology (Oxford) 57:777\u2013783","journal-title":"Rheumatology (Oxford)"},{"key":"5171_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/BOR.0000000000000052","volume":"26","author":"M Drent","year":"2014","unstructured":"Drent M, Cremers JP, Jansen TL (2014) Pulmonology meets rheumatology in sarcoidosis: a review on the therapeutic approach. Curr Opin Rheumatol 26:276\u2013284","journal-title":"Curr Opin Rheumatol"},{"key":"5171_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2147\/IJGM.S44542","volume":"6","author":"C Banse","year":"2013","unstructured":"Banse C, Bisson-Vaivre A, Kozyreff-Meurice M, Vittecoq O, Goeb V (2013) No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis. Int J Gen Med 6:605\u2013611","journal-title":"Int J Gen Med"},{"key":"5171_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.565420","volume":"7","author":"C Cacciatore","year":"2020","unstructured":"Cacciatore C, Belnou P, Thietart S, Desthieux C, Versini M, Abisror N et al (2020) Acute and chronic sarcoid arthropathies: characteristics and treatments from a retrospective nationwide french study. Front Med (Lausanne) 7:565420","journal-title":"Front Med (Lausanne)"},{"key":"5171_CR19","first-page":"98","volume":"33","author":"F Fayad","year":"2006","unstructured":"Fayad F, Liote F, Berenbaum F, Orcel P, Bardin T (2006) Muscle involvement in sarcoidosis: a retrospective and followup studies. J Rheumatol 33:98\u2013103","journal-title":"J Rheumatol"},{"key":"5171_CR20","first-page":"87","volume":"59","author":"S Garg","year":"2011","unstructured":"Garg S, Malaviya AN, Kapoor S, Rawat R, Agarwal D, Sharma A (2011) Acute inflammatory ankle arthritis in northern India\u2013Lofgren\u2019s syndrome or Poncet\u2019s disease? J Assoc Physicians India 59:87\u201390","journal-title":"J Assoc Physicians India"},{"key":"5171_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/rheumatology\/34.1.45","volume":"34","author":"A Glennas","year":"1995","unstructured":"Glennas A, Kvien TK, Melby K, Refvem OK, Andrup O, Karstensen B et al (1995) Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 34:45\u201350","journal-title":"Br J Rheumatol"},{"key":"5171_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/RHU.0000000000000185","volume":"21","author":"K Loupasakis","year":"2015","unstructured":"Loupasakis K, Berman J, Jaber N, Zeig-Owens R, Webber MP, Glaser MS et al (2015) Refractory sarcoid arthritis in World Trade Center-exposed New York City firefighters: a case series. J Clin Rheumatol 21:19\u201323","journal-title":"J Clin Rheumatol"},{"key":"5171_CR23","first-page":"212","volume":"20","author":"J Mana","year":"2003","unstructured":"Mana J, Montero A, Vidal M, Marcoval J, Pujol R (2003) Recurrent sarcoidosis: a study of 17 patients with 24 episodes of recurrence. Sarcoidosis Vasc Diffuse Lung Dis 20:212\u2013221","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"5171_CR24","first-page":"60","volume":"36","author":"ER Miller","year":"2019","unstructured":"Miller ER, Fanta CH, McSparron JI, Pan B, Coblyn JS, Sparks JA (2019) Musculoskeletal and pulmonary outcomes of sarcoidosis after initial presentation of osseous involvement. Sarcoidosis Vasc Diffuse Lung Dis 36:60\u201373","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"5171_CR25","first-page":"521","volume":"11","author":"JL Perruquet","year":"1984","unstructured":"Perruquet JL, Harrington TM, Davis DE, Viozzi FJ (1984) Sarcoid arthritis in a North American Caucasian population. J Rheumatol 11:521\u2013525","journal-title":"J Rheumatol"},{"key":"5171_CR26","first-page":"113","volume":"24","author":"D Petursdottir","year":"2007","unstructured":"Petursdottir D, Haraldsdottir SO, Gislason T, Gudbjornsson B (2007) Clinical manifestation, prevalence and prognosis of sarcoid arthropathy. A nationwide study: the Icelandic Sarcoidosis Study. Sarcoidosis Vasc Diffuse Lung Dis 24:113\u2013120","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"5171_CR27","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1212\/WNL.0b013e318212aafb","volume":"76","author":"G Androdias","year":"2011","unstructured":"Androdias G, Maillet D, Marignier R, Pinede L, Confavreux C, Broussolle C et al (2011) Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy. Neurology 76:1168\u20131172","journal-title":"Neurology"},{"key":"5171_CR28","doi-asserted-by":"crossref","unstructured":"Banse C, Bisson-Vaivre A, Kozyreff-Meurice M, Dominique S, Vittecoq O, Goeb V. Impact of TNF antagonists on the joint manifestations of sarcoidosis. Annals of the Rheumatic Diseases Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR,2013.","DOI":"10.2147\/IJGM.S44542"},{"key":"5171_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00002281-200101000-00014","volume":"13","author":"J Barnard","year":"2001","unstructured":"Barnard J, Newman LS (2001) Sarcoidosis: immunology, rheumatic involvement, and therapeutics. Curr Opin Rheumatol 13:84\u201391","journal-title":"Curr Opin Rheumatol"},{"key":"5171_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4081\/reumatismo.2013.721","volume":"65","author":"S Bello","year":"2014","unstructured":"Bello S, Bonali C, Serafino L, Rotondo C, Terlizzi N, Lapadula G (2014) Intra-articular therapy with tumor necrosis factor-\u03b1 antagonists: an update. Reumatismo 65:257\u2013263","journal-title":"Reumatismo"},{"key":"5171_CR31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jbspin.2019.07.009","volume":"86","author":"I Ben Hassine","year":"2019","unstructured":"Ben Hassine I, Rein C, Comarmond C, Glanowski C, Saidenberg-Kermanac\u2019h N, Meunier B et al (2019) Osseous sarcoidosis: a multicenter retrospective case-control study of 48 patients. Joint Bone Spine 86:789\u2013793","journal-title":"Joint Bone Spine"},{"key":"5171_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2217\/imt.15.25","volume":"7","author":"HA Crommelin","year":"2015","unstructured":"Crommelin HA, Vorselaars AD, van Moorsel CH, Korenromp IH, Deneer VH, Grutters JC (2015) Is there evidence for anti-TNF drugs in joint involvement in sarcoidosis? Immunotherapy 7:601","journal-title":"Immunotherapy"},{"key":"5171_CR33","first-page":"505","volume":"77","author":"C Glanowski","year":"2018","unstructured":"Glanowski C, Mestiri R, Bial\u00e9 L, Carmoi T, Lechevalier D, Leroux G et al (2018) THU0612 Bone sarcoidosis: a retrospective multicenter study of 27 cases. Ann Rheum Dis 77:505","journal-title":"Ann Rheum Dis"},{"key":"5171_CR34","unstructured":"Hassine I, Rein C, Comarmond C, Chapelon-Abric C, Saidenberg N, Meunier B, et al. Bone sarcoidosis: a french case control study. 2018 ACR\/ARP Annual Meeting, Oct 2018; Chicago, United States: Arthritis Rheumatol., 70 (suppl 10). Abstract Number: 2259. \u27e8hal-01998033\u27e9; 2018. p. 2495."},{"key":"5171_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/art.20936","volume":"52","author":"K Hobbs","year":"2005","unstructured":"Hobbs K (2005) Chronic sarcoid arthritis treated with intraarticular etanercept. Arthritis Rheum 52:987\u2013988","journal-title":"Arthritis Rheum"},{"key":"5171_CR36","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1002\/art.30348","volume":"63","author":"A Huang","year":"2011","unstructured":"Huang A, Harty LC, Ryan CM, Veale DJ (2011) Clinical images: infliximab therapy of polyarticular small joint sarcoid arthritis. Arthritis Rheum 63:2030","journal-title":"Arthritis Rheum"},{"key":"5171_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0049-0172(76)80005-4","volume":"6","author":"DG James","year":"1976","unstructured":"James DG, Neville E, Carstairs LS (1976) Bone and joint sarcoidosis. Semin Arthritis Rheum 6:53\u201381","journal-title":"Semin Arthritis Rheum"},{"key":"5171_CR38","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1749-6632.1986.tb18549.x","volume":"465","author":"CJ Johns","year":"1986","unstructured":"Johns CJ, Schonfeld SA, Scott PP, Zachary JB, MacGregor MI (1986) Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications. Ann N Y Acad Sci 465:702\u2013712","journal-title":"Ann N Y Acad Sci"},{"key":"5171_CR39","first-page":"1864","volume":"30","author":"D Khanna","year":"2003","unstructured":"Khanna D, Liebling MR, Louie JS (2003) Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 30:1864\u20131867","journal-title":"J Rheumatol"},{"key":"5171_CR40","doi-asserted-by":"crossref","unstructured":"Madronal Garcia I. Joint manifestations in a cohort of patients with sarcoidosis in a third level hospital. Annual European Congress of Rheumatology, EULAR 2020 Germany2020. p. 1814.","DOI":"10.1136\/annrheumdis-2020-eular.6444"},{"key":"5171_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007595","volume":"96","author":"J Mana","year":"2017","unstructured":"Mana J, Rubio-Rivas M, Villalba N, Marcoval J, Iriarte A, Molina-Molina M et al (2017) Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona. Spain Med (Baltimore) 96:e7595","journal-title":"Spain Med (Baltimore)"},{"key":"5171_CR42","first-page":"997","volume":"78","author":"JL Mart\u00edn-Varillas","year":"2019","unstructured":"Mart\u00edn-Varillas JL, Bilbao LS, Gonz\u00e1lez-Maz\u00f3n I, Ram\u00f3n RF, Prieto-Pe\u00f1a D, Martinez-Lopez D et al (2019) FRI0604 Systemic sarcoidosis Study of 381 patients from a tertiary university hospital in the north of Spain. Ann Rheumatic Dis 78:997","journal-title":"Ann Rheumatic Dis"},{"key":"5171_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00002281-199305010-00014","volume":"5","author":"A Mathur","year":"1993","unstructured":"Mathur A, Kremer JM (1993) Immunopathology, musculoskeletal features, and treatment of sarcoidosis. Curr Opin Rheumatol 5:90\u201394","journal-title":"Curr Opin Rheumatol"},{"key":"5171_CR44","first-page":"141","volume":"115","author":"T Medici","year":"1977","unstructured":"Medici T, Mannhart R, Tanner E (1977) Effect of steroid therapy on acute sarcoidosis (Loefgren\u2019s syndrome). Am Rev Respir Dis 115:141","journal-title":"Am Rev Respir Dis"},{"key":"5171_CR45","first-page":"525","volume":"52","author":"E Neville","year":"1983","unstructured":"Neville E, Walker AN, James DG (1983) Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 52:525\u2013533","journal-title":"Q J Med"},{"key":"5171_CR46","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s00198-017-4115-z","volume":"28","author":"OA Oshagbemi","year":"2017","unstructured":"Oshagbemi OA, Driessen JHM, Pieffers A, Wouters EFM, Geusens P, Vestergaard P et al (2017) Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis. Osteoporos Int 28:2859\u20132866","journal-title":"Osteoporos Int"},{"key":"5171_CR47","first-page":"2496","volume":"70","author":"S Patil","year":"2018","unstructured":"Patil S, Arakane M, Jenigiri S, Field E, Singh N (2018) Musculoskeletal sarcoidosis: a 15-year experience from a tertiary care center in the us. Arthr Rheumatol 70:2496\u20132497 (PubMed PMID: 626435339)","journal-title":"Arthr Rheumatol"},{"key":"5171_CR48","first-page":"1","volume":"2019","author":"S Retamozo","year":"2019","unstructured":"Retamozo S (2019) ACR\/ARP annual meeting abstract supplement. Arthritis Rheumatol 2019:1\u20135362","journal-title":"Arthritis Rheumatol"},{"key":"5171_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2019.03.013","volume":"152","author":"M Rubio-Rivas","year":"2019","unstructured":"Rubio-Rivas M, Corbella X, Mana J (2019) Elderly sarcoidosis: a comparative study from a 42-year single-centre experience. Respir Med 152:1\u20136","journal-title":"Respir Med"},{"key":"5171_CR50","unstructured":"Russell E, O'Connor C, Hussain H. Long term follow-up of infliximab efficacy in pulmonary and extrapulmonary sarcoidosis refractory to conventional therapy. Arthritis and Rheumatism Conference: Annual Scientific Meeting of the American College of Rheumatology and Association of Rheumatology Health Professionals 20112011."},{"key":"5171_CR51","unstructured":"Schmajuk G, editor Patterns of Medication Use for Patients with Sarcoidosis: Data from the ACR \u2019 s RISE Registry. 2019 ACR\/ARP Annual Meeting November 8\u201313, 2019; 2019; Atlanta."},{"key":"5171_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1573397114666180425111901","volume":"15","author":"S Somayeh","year":"2019","unstructured":"Somayeh S, Roshanak S, Maryam S, Payman Shalchian T, Masoumeh S (2019) Musculoskeletal manifestations of sarcoidosis: a review article. Curr Rheumatol Rev 15:83\u201389","journal-title":"Curr Rheumatol Rev"},{"key":"5171_CR53","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.medcli.2014.02.029","volume":"143","author":"B Tejera Segura","year":"2014","unstructured":"Tejera Segura B, Holgado S, Mateo L, Pego-Reigosa JM, Carnicero Iglesias M, Oliv\u00e9 A (2014) L\u00f6fgren syndrome: a study of 80 cases. Med Clin (Barc) 143:166\u2013169","journal-title":"Med Clin (Barc)"},{"key":"5171_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.semarthrit.2017.02.004","volume":"47","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Lower EE, Li H, Farhey Y, Baughman RP (2017) Clinical characteristics of patients with bone sarcoidosis. Semin Arthritis Rheum 47:143\u2013148","journal-title":"Semin Arthritis Rheum"},{"key":"5171_CR55","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/17476348.2016.1227244","volume":"10","author":"B Strookappe","year":"2016","unstructured":"Strookappe B, Saketkoo LA, Elfferich M, Holland A, De Vries J, Knevel T et al (2016) Physical activity and training in sarcoidosis: review and experience-based recommendations. Expert Rev Respir Med 10:1057\u20131068","journal-title":"Expert Rev Respir Med"},{"key":"5171_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4187\/respcare.04312","volume":"61","author":"MN Karadalli","year":"2016","unstructured":"Karadalli MN, Bosnak-Guclu M, Camcioglu B, Kokturk N, Turktas H (2016) Effects of inspiratory muscle training in subjects with sarcoidosis: a randomized controlled clinical trial. Respir Care 61:483\u2013494","journal-title":"Respir Care"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05171-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05171-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05171-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T11:56:09Z","timestamp":1665402969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05171-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5171"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05171-8","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"25 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}